Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
180,647
Value
$6.12M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TEVA by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026180,647$6.12M<0.1%+40,574+29.0%AddedHolders
Q1 2026140,073$4.22M<0.1%−507,038−78.4%ReducedHolders
Q4 2025647,111$20.2M<0.1%+477,944+282.5%AddedHolders
Q3 2025169,167$3.42M<0.1%+47,346+38.9%AddedHolders
Q2 2025121,821$2.04M<0.1%+40,637+50.1%AddedHolders
Q1 202581,184$1.25M<0.1%−2,427,905−96.8%ReducedHolders
Q4 20242,509,089$55.3M0.1%−1,145,369−31.3%ReducedHolders
Q3 20243,654,458$65.9M0.1%−2,230,589−37.9%ReducedHolders
Q2 20245,885,047$95.6M0.1%+3,966,146+206.7%AddedHolders
Q1 20241,918,901$27.1M<0.1%+404,319+26.7%AddedHolders
Q4 20231,514,582$15.8M<0.1%−4,524,093−74.9%ReducedHolders
Q3 20236,038,675$61.6M0.1%+582,945+10.7%AddedHolders
Q2 20235,455,730$41.1M0.1%+4,039,979+285.4%AddedHolders
Q1 20231,415,751$12.5M<0.1%−803,544−36.2%ReducedHolders
Q4 20222,219,295$20.2M<0.1%−1,725,040−43.7%ReducedHolders
Q3 20223,944,335$31.8M0.1%+2,631,829+200.5%AddedHolders
Q2 20221,312,506$9.87M<0.1%−2,314,089−63.8%ReducedHolders
Q1 20223,626,595$34.1M<0.1%+1,455,442+67.0%AddedHolders
Q4 20212,171,153$17.4M<0.1%−527,500−19.5%ReducedHolders
Q3 20212,698,653$26.3M<0.1%+2,595,704+2,521.3%AddedHolders
Q2 2021102,949$1.02M<0.1%+28,156+37.6%AddedHolders
Q1 202174,793$863.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.